Octreotide therapy for control of acute gastrointestinal bleeding in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 38, Issue 1, 2004, Pages 41-47

  Eroglu, Y ^a   Emerick, K M ^a   Whitingon, P F ^a   Alonso, Estella M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Gastrointestinal bleeding; Octreotide; Portal hypertension

Indexed keywords

OCTREOTIDE; VITAMIN K GROUP; GASTROINTESTINAL AGENT; HEMOSTATIC AGENT;

AGITATION; BRADYCARDIA; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HUMAN; INFANT; LIVER DISEASE; MALE; MORTALITY; PORTAL HYPERTENSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SIDE EFFECT; ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; CHILD; INTRAVENOUS DRUG ADMINISTRATION; RECURRENT DISEASE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HEMOSTATICS; HUMANS; HYPERTENSION, PORTAL; INFANT; INFUSIONS, INTRAVENOUS; MALE; OCTREOTIDE; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 3142642632     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200401000-00011     Document Type: Review

References (36)

1. Jenkins SA, Poulianos G, Coraggio F, et al. Somatostatin in the treatment of non-variceal upper gastrointestinal bleeding. Dig Dis 1998;16:214-24.
2. Pringle SD, McKee RF, Garden OJ, et al. The effect of a long-acting somatostatin analogue on portal and systemic haemodynamics in cirrhosis. Aliment Pharmacol Ther 1988;2:451-9.
3. McCormick PA, Dick R, Siringo S, et al. Octreotide reduces azygous blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990;2:489-92.
4. Karrer FM, Narkewicz MR. Esophageal varices: current management in children. Semin Pediatr Surg 1999;8(4):193-201.
5. Mowat AP. Prevention of variceal bleeding. J Pediatr Gastroenterol Nutr 1986;5:679-87.
6. Fonkalsrud EW. Treatment of variceal hemorrhage in children. Surg Clin North Am 1990;70:475-87.
7. El Atti EA, Nevens F, Bogaerts K, et al. Variceal pressure is a strong predictor of variceal hemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension. Gut 1999;45:618-21.
8. Lin HC, Tsai YT, Lee FY, et al. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology 1992;103:229-34.
9. Navasa M, Bosch J, Chesta J, et al. Haemodynamic effects of subcutaneous administration of SMS 201-995, a long-acting somatostatin analogue in patients with cirrhosis and portal hypertension (abstract). J Hepatol 1988;7(Suppl):S64.
10. Eriksson LS, Brundin T, Soderlund C, et al. Haemodynamic effects of a long acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987;22:919-25.
11. Escorsell A, Feu F, Garcia-Pagan JC, et al. Hemodynamic effects of octreotide in cirrhotic patients with portal hypertension, A double-blind study (abstract), J Hepatol 1995;23(Suppl 1):85.
12. Jenkins SA, Baxter JN, Corbett WA, et al. Effects of a somatostatin analogue SMS 201-995 on hepatic hemodynamic in the pig and on variceal pressure in man, Br J Surg 1985;72:1009-12.
13. Cello JP, Chan MF. Octreotide therapy for variceal hemorrhage. Digestion 1993;54(Suppl 1):20-6.
14. McKee R. A study of octreotide in esophageal varices, Digestion 1990;45(Suppl):60-4.
15. Corley DA, Cello JP, Adkisson W, et al. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 2001;120:946-54.
16. Siafakas C, Fox VL, Nurko S. Use of octreotide for the treatment of severe gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 1998;26:356-9.
17. Zellos A, Schwartz KB. Efficacy of octreotide in children with chronic gastrointestinal bleeding. J Pediatr Gastroenterol Nutr 2000;30:442-6.
18. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension. A meta-analytic review. Hepatology 1995;22:332-54.
19. D'Amico G, Montalbano L, Traina M, et al. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990;99;1558-64.
20. Gostout CJ, Viggiano TR, Balm RK. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol 1993;88:2030-3.
21. Kitano S, Dolgor B. Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? J Gastroenterol 2000;35:79-86.
22. Kouroumalis EA, Koutroubakis IE, Manousos ON. Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol 1998;10:509-12.
23. Freitas DS, Sofia C, Pontes JM, et al. Octreotide in acute bleeding esophageal varices: a prospective randomized study. Hepatogastroenterology 2000;47:1310-4.
24. Besson I, Ingrand P, Person B, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.
25. Sung JJY, Chung SCS, Lai CW, et al. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993;342:637-41.
26. Jenkins SA, Shields R, Davies M, et al. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut 1997;41:526-33
27. Bildozola M, Kravetz D, Argonz J, et al. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. Scand J Gastroenterol 2000;35:419-25.
28. Whitehouse I, Beglinger C, Fried M, et al. The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 on pentagastrin- stimulated gastric acid secretion: a comparative study in man. Hepatogastroenterologica 1984;31:227-9.
29. Whitehouse I, Beglinger C, Ruettimann C, et al. Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue. Gut 1986;27:141-6.
30. Olson JA, Loud FB, Christianssen J. Inhibition of meal stimulated gastric acid secretion by the octapeptide somatostatin analogue SMS 201-995. Gut 1987;28:464-7.
31. Christiansen J, Ottenjann R, Von Arx F. Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding. Gastroenterology 1989;97:468-574.
32. Jenkins SA, Taylor BA, Nott DM, et al. Management of massive upper gastrointestinal haemorrhage from multiple sites of peptic ulceration with somatostatin and octreotide: a report of five cases. Gut 1992;33:404-7.
33. Lin HJ, Perng CL, Wang K, et al. Octreotide for arrest of peptic ulcer haemorrhage: A prospective, randomized controlled trial. Hepatogastroenterology 1995;42:856-60.
34. Lamberts SWJ, van der Lely AJ, de Herder WW, et al. Octreotide. N Engl J Med 1996;334:246-54.
35. McCormick PA, Chin J, Greenslade L, et al. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995;21:1255-60.
36. Drouin E, Martin S, Alvarez F. Hepatic decompensation in a child with biliary atresia on octreotide perfusion (abstract). J Pediatr Gastroenterol Nutr 1999;29:512.